Figure 3. The histologic sections of the retina with hematoxylin and eosin (HE) staining 7 days after intravitreal injection of 5 µl of 3.75 mg/ml bevacizumab (A), 15 µg/ml anti-rat vascular endothelial growth factor (VEGF) antibody (B), 1 mg/ml rat immunoglobulin G (IgG; C), and physiologic saline (D). E–H are the fluorescence images of glial fibrillary acidic protein (GFAP)-immunolabeled sections 7 days after intravitreal injection of bevacizumab (E), anti-rat VEGF antibody (F), rat IgG (G), and physiologic saline (H). The scale bar represents 20 µm.